Skip to main content

Find Clinical Trials

Home
Conditions
Herpesviridae Infections

Clinical trial condition

Herpesviridae Infections

Explore clinical trials studying Herpesviridae Infections. Study availability and eligibility vary by location and protocol.

1,824 public trials 252 recruiting studies

Refine in advanced search Browse all conditions

Herpesviridae Infections trial results

Completed

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00536601

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +137 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes

NCT01281007

Conditions: Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +18 more
Locations: Centro de Medicina Reprodutiva Dr Carlos Isaia Filho Ltda Porto Alegre, Rio Grande do Sul, Brazil

Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil

SPVita Bragança Paulista, São Paulo, Brazil

Caep Centro Avancado de Estudos E Pesquisas Ltda Campinas, São Paulo, Brazil

View Trial Details

Completed

Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)

NCT03843632

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations: Republican Clinical Infectious Hospital n.a. A.F. Agafonov ( Site 5816) Kazan', Russia

Research Institute of Children Infections ( Site 5801) Saint Petersburg, Russia

SPb Pasteur RI of Epidemiology and Microbiology ( Site 5817) Saint Petersburg, Russia

Smolensk State Medical University ( Site 5814) Smolensk, Russia

View Trial Details

Completed

Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age

NCT03314103

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Hunan Provincial Center for Disease Control and Prevention Loudi, Hunan, China

Jiangsu Province Centers for Disease Control and Prevention Nanjing, Jiangsu, China

Zhejiang Provincial Center for Disease Control and Prevention Hanzhou, Zhejiang, China

View Trial Details

Completed

Kabat Technique and Neuromuscular Effect in Patients With Bell's Palsy

NCT04807491

Conditions: Bell Palsy, Cranial Nerve Diseases, DNA Virus Infections, +12 more
Locations: Riphah International University Islamabad, Pakistan

View Trial Details

Completed

Reducing Acquisition of CMV Through Antenatal Education

NCT03511274

Conditions: Cytomegalovirus Congenital, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations: St George's, University of London London, United Kingdom

View Trial Details

Completed

Risk Factors for Non-HIV-Related Kaposi s Sarcoma

NCT00339326

Conditions: DNA Virus Infections, Herpesviridae Infections, Infections, +8 more
Locations: Universita Degli Studi Di Palermo Palermo, Italy

View Trial Details

Completed

Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00278421

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations: Haematologisch Onkologische Praxis Aachen, Germany

Klinikum Augsburg Augsburg, Germany

Klinikum Bayreuth Bayreuth, Germany

Haematologisch-Onkologische Schwerpunktpraxis - Weilheim Berlin, Germany

View all 78 locations

View Trial Details

Completed

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

NCT01276236

Conditions: DNA Virus Infections, Herpesviridae Infections, Infections, +8 more
Locations: San Francisco General Hospital, Clinical Trials Unit San Francisco, California, United States

View Trial Details

Completed

Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.

NCT02690207

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: GSK Investigational Site Mesa, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

View all 195 locations

View Trial Details